Personal Views of Aging in Parkinson’s Disease: How Do They Relate to Clinical, Cognitive and Behavioral Functioning?
Objective: To explore the impact of personal views of aging in Parkinson’s Disease (PD) and how they relate to clinical, cognitive, and behavioural outcomes compared…Improving Equitable Access to Parkinson’s Disease Exercise Programs Through a Student-Led Transportation Model
Objective: To evaluate the feasibility and impact of a student-led transportation model designed to improve access to evidence-based exercise programs for people with Parkinson’s disease…Boosting cerebellum/M1 and PPC/M1 communication via tACS to improve cued gait in Parkinson’s disease patients unresponsive to auditory cueing strategies.
Objective: This study aims to test the contribution of Posterior Parietal Cortex – primary motor cortex and cerebellum - M1 pathways in decreasing gait variability…Disease Endophenotyping through Graph and Adjacency Metrics (DEGAS): Network Biomarkers for Parkinson’s Disease Prognosis
Objective: To develop a machine learning framework using resting-state functional connectivity to identify neural signatures of Parkinson's disease (PD) and forecast disease progression. Background: PD…Outcomes from Unilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Advanced Parkinson’s Disease
Objective: To evaluate the safety, efficacy, and patient-reported outcomes of unilateral MRgFUS pallidothalamic tractotomy (PTT) for the treatment of aPD. Background: In July 2025, the…Can digital Mobility Outcomes differentiate cognitive impairment in Parkinson’s Disease?
Objective: To determine if digital mobility outcomes (DMOs) differentiate between those with and without cognitive impairment in Parkinson’s disease (PD). Background: Cognitive impairment is common…Lack of Association Between Polygenic Risk Scores for Parkinson’s Disease and Age at Onset, Freezing of Gait, or Psychosis
Objective: To evaluate whether the polygenic risk scores of Parkinson’s disease (PD-PRS) is associated with age at disease onset (AAO), freezing of gait (FOG) or…Association of Triglycerides, LDL, and IL-6 with Non-Motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study
Objective: To analyze the association between serum levels of low-density lipoprotein (LDL), triglycerides, and interleukin-6 (IL-6) with non-motor symptoms in patients with Parkinson’s disease. Background:…Apparent Change Classification with Stage-Specific and Fixed Minimal Detectable Change Thresholds in Parkinson’s Disease
Objective: To compare whether stage-specific and fixed minimal detectable change (MDC) thresholds yield different classifications of apparent change in repeated within-session 10-meter walk test (10MWT)…Outcomes of Bilateral Deep Brain Stimulation Following Prior MR-guided Focused Ultrasound Thalamotomy
Objective: To evaluate the safety and efficacy of subsequent Deep Brain Stimulation (DBS) as a management strategy for patients with recurrent or residual symptoms following MR-guided Focused Ultrasound (MRgFUS) thalamotomy. Background: Despite its…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 553
- Next Page »